Appili Therapeutics Signs $3M USD Grant Contract with the United States Department of Defense to Develop Antibiotics that Target Superbugshttps://finance.yahoo.com/news/appili-therapeutics-signs-3m-usd-111700766.html
2019-07 Appili, the Department of Defense and the ATI-1503 antibiotic program
Appili signs $3M grant contract with the US Defensehttps://www.biospectrumindia.com/news/57/14111/appili-signs-3m-grant-contract-with-the-us-defense-.html
2019-07 Appili, the Department of Defense and the ATI-1503 antibiotic program
Halifax's Appili Therapeutics wins U.S. grant to develop antibiotics that target superbugs | Business | The Chronicle Heraldhttps://www.thechronicleherald.ca/business/halifax-company-gets-us-defence-dept-grant-329798/
2019-07 Appili, the Department of Defense and the ATI-1503 antibiotic program

Showing topic

2019-07 Appili, the Department of Defense and the ATI-1503 antibiotic program
Pharmaceutical makers, antibiotic resistance and the development of new drugs